XCancer Omaha

Omaha, Nebraska 68130

2 studies enrolling now · 8 studies all time

What they study most

Advanced Metastatic Castration-resistant Prostate Cancer, Biochemically Recurrent Prostate Cancer, Cancer, Castration-Resistant Prostate Cancer, Castration-Resistant Prostate Cancer (CRPC), Metastatic Castration-resistant Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer, Prostate Cancer, Prostate Cancer (Adenocarcinoma), Prostate Specific Membrane Antigen (PSMA) Expression

Studies at this site

• Study of Oral MRT-2359 With Apalutamide in Prostate Cancer — Recruiting now
• The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global) — Recruiting now
• First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) — Recruiting now
• Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer — Running, not enrolling
• A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies — Running, not enrolling
• A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) — Running, not enrolling
• A Study to Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study. — Running, not enrolling
• A Clinical Study of ONCT-534 in Subjects With Metastatic Castration-resistant Prostate Cancer. — Stopped early